Ravi Kant

Ravi Kant is an Assistant Professor at Shoolini University and a skilled Computational Biologist. He has completed Post-Doctoral Research from the Faculty of Medicine, University of Southampton, England. He has research experience spanning across countries like the UK, USA, Brazil, Malaysia, Japan, Canada, Germany, and Costa Rica, as well as from Africa. In India, he has worked with top institutions such as the University of Delhi, Central University of Jammu, IGDTUW Delhi, and AIIMS Delhi. He holds a PhD and MPhil from the University of Delhi and a master's degree from Haryana Agriculture University, Hisar. 

His research expertise lies in drug and vaccine discovery, computational biology, and translational research, with a focus on homology modeling, molecular docking, pharmacophore generation, molecular dynamics simulations, and AI-driven approaches to accelerate therapeutics and vaccine development. He has made significant contributions in addressing antimicrobial resistance and infectious diseases, particularly sexually transmitted infections (STIs) and multidrug-resistant pathogens, while fostering academia–industry collaborations worldwide.  

Asst Prof Kant’s outstanding contributions have been recognised with several prestigious awards, including the Bill & Melinda Gates Foundation Fellowship/Travel Grant (10 times), the 13th Norman L. Letvin Early Career Investigator Grant (Gates Foundation), the NIHR Southampton Biomedical Research Centre Career Development Award (UK), multiple Young Investigator and Young Scientist Awards, and the BBSRC-UKRI International Partnership Funding (UK Government). He has also successfully engaged with competitive research grants from Indian funding agencies such as ICMR, and international agencies including NIHR and BBSRC-UKRI (this funding was granted to and won by Prof. Myron Christodoulides at the University of Southampton, where he worked as a visiting researcher in Prof. Myron’s lab for three months). His most recent success story includes the highly competitive grant funding won by his Brazilian collaborators to develop a novel vaccine for Leishmania – a neglected tropical disease. This project is funded by a research network led by The University of Oxford, England, where Prof Myron Christodoulides (University of Southampton, UK) and Asst Prof Ravi Kant (Shoolini University, India) are serving as International Collaborators based on their expertise.  

At Shoolini University, Asst Prof Kant is committed to mentoring Master’s and PhD students and researchers, advancing cutting-edge projects in the research areas of STIs & Women’s Health, Infectious Diseases, and Antimicrobial Resistance (AMR), and building strong international partnerships to establish Shoolini as a hub for excellence in biotechnology and vaccine discovery & development.